Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
106.86 USD
-0.03%
Market Closed
Updated:
Apr 26, 2024
Abbott Laboratories
Accrued Liabilities
|
Abbott Laboratories
Accrued Liabilities Peer Comparison
Comparables:
BDX
BSX
SYK
ISRG
DXCM
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$691.4m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Accrued Liabilities
$1.3B
|
CAGR 3-Years
41%
|
CAGR 5-Years
54%
|
CAGR 10-Years
48%
|
See Also
What is Abbott Laboratories's Accrued Liabilities?
Accrued Liabilities
7B
USD
7B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Accrued Liabilities amounts to 7B USD.
What is Abbott Laboratories's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
6%
6%
Over the last year, the Accrued Liabilities growth was 2%. The average annual Accrued Liabilities growth rates for Abbott Laboratories have been 3% over the past three years , 7% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
